MediMix Oncology
  • Home
  • Congresses
    • 2026
      • ESMO GI 2026
      • ASCO 2026
      • ELCC 2026
      • ENETS 2026
      • BSMO 50 YEARS
      • ASCO GU 2026
      • ASCO GI 2026
    • 2025
      • SABCS 2025
      • SIOG 2025
      • ESMO 2025
      • WCLC 2025
      • EADO 2025
  • STiP
  • Webinars
    • ESDO – GI Cancer – ASCO GI 2026
    • ESDO GI Cancer – ESMO 2025
  • Contact
  • Other specialties
    • Dermatology
    • Hematology
    • Respirology
    • Cardiology
    • Rheumatology
    • Neurology
  • SIGN UP
  • SIGN IN
    • Login
    • Account
WCLC 2023

Definition of resectable stage III NSCLC: a systematic literature review

17 September 2023

Dr Eleni Xenophontos, a medical oncologist and clinical research physician at the European Organisation for Research and Treatment of Cancer (EORTC) in Brussels, presented a systematic literature review that was part of a global EORTC Lung Cancer Group initiative to provide a consensual definition on resectability in stage III NSCLC. By means of a systematic review of the literature from 2007-2023, they aimed to identify the definitions used by investigators when to proceed to surgery in stage III; the medical specialties involved in the decision and the work-up required for the decision process.

With the educational support of:

Tags:

poster

Share Article

Website created by MediMix © 2026 - Privacy Policy

  • Home
  • Congresses
    • 2026
      • ESMO GI 2026
      • ASCO 2026
      • ELCC 2026
      • ENETS 2026
      • BSMO 50 YEARS
      • ASCO GU 2026
      • ASCO GI 2026
    • 2025
      • SABCS 2025
      • SIOG 2025
      • ESMO 2025
      • WCLC 2025
      • EADO 2025
  • STiP
  • Webinars
    • ESDO – GI Cancer – ASCO GI 2026
    • ESDO GI Cancer – ESMO 2025
  • Contact
  • Other specialties
    • Dermatology
    • Hematology
    • Respirology
    • Cardiology
    • Rheumatology
    • Neurology
  • SIGN UP
  • SIGN IN
    • Login
    • Account
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.